Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Jansen

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Atherosclerosis|March 14, 2007
Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetryAntonio Alcalá, Sergio Jansen, Michael E Farkouh, et al.
Plants (Basel, Switzerland)|January 8, 2025
Conflicting Dynamics of Galling and Pollination: <i>Arastichus gallicola</i> (Hymenoptera, Eulophidae), a Specialized Parasitic Galler in Pistillate Flowers of <i>Thaumatophyllum bipinnatifidum</i> (Araceae)Sergio Jansen-González, Simone P Teixeira, Rodrigo A S Pereira
Journal of Diabetes|October 10, 2013
Glucocorticoid-induced hyperglycemiaAntonio Perez, Sergio Jansen-Chaparro, Ignasi Saigi, et al.
Atherosclerosis|November 7, 2009
Statins improve visual field alterations related to hypercholesterolemiaAntonio Alcalá, Sergio Jansen, Teresa Téllez, et al.
Frontiers in Cardiovascular Medicine|December 9, 2021
Statins and Peripheral Arterial Disease: A Narrative ReviewSergio Jansen-Chaparro, María D López-Carmona, Lidia Cobos-Palacios, et al.
Diabetes Research and Clinical Practice|March 23, 2011
Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care)M Rosa Bernal-Lopez, Aurora Villalobos-Sanchez, Jose Mancera-Romero, et al.
European Journal of Internal Medicine|August 7, 2012
Metabolic syndrome and vascular risk estimation in a Mediterranean non-diabetic population without cardiovascular diseaseSergio Jansen-Chaparro, Jose Mancera, Jose I Cuende, et al.
Panminerva Medica|April 21, 2021
Management of older hospitalized patients with type 2 diabetes using linagliptin: Lina-Older studyLuis M Pérez-Belmonte, Julio Osuna-Sánchez, Michele Ricci, et al.
Journal of Clinical Medicine|April 14, 2019
Trends in Diabetes-Related Potentially Preventable Hospitalizations in Adult Population in Spain, 1997⁻2015: A Nation-Wide Population-Based StudyRicardo Gómez-Huelgas, Carmen M Lara-Rojas, María D López-Carmona, et al.
Journal of Clinical Medicine|June 2, 2021
De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF StudyLuis M Pérez-Belmonte, Michele Ricci, Jaime Sanz-Cánovas, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Atherosclerosis|March 14, 2007
Hypercholesterolemia is associated with visual field alterations detectable with computerized perimetryAntonio Alcalá, Sergio Jansen, Michael E Farkouh, et al.
Plants (Basel, Switzerland)|January 8, 2025
Conflicting Dynamics of Galling and Pollination: <i>Arastichus gallicola</i> (Hymenoptera, Eulophidae), a Specialized Parasitic Galler in Pistillate Flowers of <i>Thaumatophyllum bipinnatifidum</i> (Araceae)Sergio Jansen-González, Simone P Teixeira, Rodrigo A S Pereira
Journal of Diabetes|October 10, 2013
Glucocorticoid-induced hyperglycemiaAntonio Perez, Sergio Jansen-Chaparro, Ignasi Saigi, et al.
Atherosclerosis|November 7, 2009
Statins improve visual field alterations related to hypercholesterolemiaAntonio Alcalá, Sergio Jansen, Teresa Téllez, et al.
Frontiers in Cardiovascular Medicine|December 9, 2021
Statins and Peripheral Arterial Disease: A Narrative ReviewSergio Jansen-Chaparro, María D López-Carmona, Lidia Cobos-Palacios, et al.
Diabetes Research and Clinical Practice|March 23, 2011
Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care)M Rosa Bernal-Lopez, Aurora Villalobos-Sanchez, Jose Mancera-Romero, et al.
European Journal of Internal Medicine|August 7, 2012
Metabolic syndrome and vascular risk estimation in a Mediterranean non-diabetic population without cardiovascular diseaseSergio Jansen-Chaparro, Jose Mancera, Jose I Cuende, et al.
Panminerva Medica|April 21, 2021
Management of older hospitalized patients with type 2 diabetes using linagliptin: Lina-Older studyLuis M Pérez-Belmonte, Julio Osuna-Sánchez, Michele Ricci, et al.
Journal of Clinical Medicine|April 14, 2019
Trends in Diabetes-Related Potentially Preventable Hospitalizations in Adult Population in Spain, 1997⁻2015: A Nation-Wide Population-Based StudyRicardo Gómez-Huelgas, Carmen M Lara-Rojas, María D López-Carmona, et al.
Journal of Clinical Medicine|June 2, 2021
De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF StudyLuis M Pérez-Belmonte, Michele Ricci, Jaime Sanz-Cánovas, et al.
Pageof 2